Dr. Anne Wiles joined Risk Sciences International (RSI) in 2008, where she currently serves as a Senior Analyst specializing in risk communication, perception, and governance. With a distinctive blend of expertise in language, regulation, and the use of science in decision-making, Anne has contributed to a wide range of RSI projects focused on the human and institutional dimensions of risk. Her work includes developing health risk communication strategies and drafting publicly accessible scientific information, advising on public messaging for nuclear energy and nuclear waste management, and supporting regulatory agencies in the evaluation and management of complex risk portfolios. She has been deeply involved in several RSI projects examining how mandates, institutional contexts, and public attitudes shape regulatory decision-making across federal domains. Anne has also contributed to scholarly work at RSI, including co-authoring a scoping review on the evolution of health and environmental risk decision-making, an article on the potential health risks associated with aluminum, and a book chapter on public concerns related to blood safety. In addition to her project work, Anne is a university instructor, teaching two courses: a broad overview of societal approaches to risk, and a graduate seminar on risk management in government, where she integrates academic theory with real-world regulatory case studies and risk communication practice.

With 45 years of experience in exposure and risk assessment, Dr. Paul Price has worked with diverse organizations, including the U.S. EPA and Dow Chemical. Specializing in mixture risk assessments, he is an adjunct professor at the University of Iowa and serves on the European Food Safety Authority’s committee on combined exposures. A prolific author, Dr. Price is currently focused on publications concerning mixture risk assessment and the Mixture Adjustment Factor.

Emma Hartnett is an internationally recognized expert in risk assessment, specializing in toxicological, microbiological, and nutritional hazards. She holds a B.Sc. in Microbiology and a Ph.D. in Statistics and Modelling Science, where her thesis work focused on quantitative risk assessment for campylobacter infection from chicken. Hartnett has developed a variety of decision support tools addressing issues from infectious diseases to bioterrorism preparedness. She frequently contributes to WHO and FAO initiatives, and has been selected for the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment Roster of Experts for 2018-2022.

Greg Paoli earned both his Bachelor's and Master's degrees from the University of Waterloo, specializing in engineering and systems design. His early career involved diverse research projects at the University of Waterloo's Institute for Risk Research. Greg later founded Decisionalysis Risk Consultants in 1997 and co-founded Risk Sciences International in 2006. He has served on multiple high-profile committees, including those under the U.S. National Academy of Sciences. As CEO of Risk Sciences International, Greg focuses on risk-based regulatory transformations and has developed enabling technologies like FDA-iRISK. His work spans various sectors, from food and chemical safety to public health, and he continues to contribute to the advancement of risk-based decision-making methodologies.

Dr. William Leiss held the NSERC/SSHRC Research Chair in Risk Communication and Public Policy at the Haskayne School of Business, University of Calgary, from 1999 to 2005. He has a substantial consulting background, collaborating with industry and various Canadian government departments on risk communication, risk management, public consultation, and multi-stakeholder consensus-building processes. Dr. Leiss has provided expertise on diverse issues, including pesticides, toxic chemicals, tobacco, prescription drugs, electric & magnetic fields, and genetic engineering. He earned his PhD from the University of California at San Diego.

Since 2002, Mr. McNair has led key aspects of Cerner's Big Data operations, ensuring data quality for over 700 healthcare institutions. His role focuses on using this data for predictive models and decision-support solutions. McNair's career at Cerner began in 1986, where he co-invented Discern Expert®, a real-time decision-support engine used globally. He held positions in regulatory affairs, served as a General Manager, and worked in pharmaceutical roles. McNair is a prominent figure in mathematical modeling, AI, and health finance, with over 100 patents and numerous publications. He's also active in volunteer work and academic pursuits.

Rosanna Wong holds a B.Sc. in Environmental Science from the University of Waterloo, with diverse co-op experiences ranging from aquaculture research in the Netherlands to botany collections in Canada. She transitioned into risk analysis, initially as a Junior Analyst at Risk Sciences International, focusing on food safety and public health. Currently, she conducts research on food safety, transportation, and climate change, and leads the development of a climate resilience tool that integrates both qualitative and quantitative data.

Dr. Arnold, a former general surgeon and occupational health consultant in Labrador and Nouveau Quebec, served Quebec Cartier Mining Ltd and the Iron Ore Company of Canada from 1973 to 1981. He has held teaching positions at various Canadian medical faculties and currently serves as an Adjunct Professor at McGill University. Dr. Arnold earned his M.D. from Queen's University in 1968 and has an extensive publication and presentation record with over 100 papers. He has received numerous honors for his contributions to occupational health and workplace psychological health and safety.

Dr. Al-Zoughool, an associate professor at Kuwait University's College of Public Health, conducts interdisciplinary research on public health risks, including chemical, biological, physical, and lifestyle factors' impact on chronic diseases such as cancer and asthma. His work involves projects like modeling emerging infectious diseases, assessing occupational asthma in healthcare, and studying air pollution's cardiovascular disease risk. He previously held positions at King Saud Bin Abdulaziz University for Health Sciences, the University of Ottawa, and the International Agency for Research on Cancer. With 38 peer-reviewed articles, three book chapters, and extensive involvement in classifying human carcinogens, Dr. Al-Zoughool is a distinguished researcher in the field.

Dr. Nataliya Karyakina brings extensive expertise in toxicology and risk assessment to RSI. With a Ph.D. in Toxicology and experience at the McLaughlin Centre for Population Health Risk Assessment, she specializes in evaluating health risks from exposure to various toxic agents. Her research spans essential and toxic metals, pharmaceuticals, and nanomaterials. She has contributed to projects on chemical classification and labeling, as well as health-based regulatory guidance. Currently, she focuses on the health effects of engineered nanoalumina and diagnostic criteria for occupational manganism.